Found 23 hits for monomerid = 50163874,50257322,50257323,50257381,50163879,50163880,50163881,50163883,50163884,50163886,50163877 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Transmembrane domain-containing protein TMIGD3
(Homo sapiens (Human)) | BDBM50163874
 (CHEMBL3800048)Show SMILES CNC(=O)[C@@]12C[C@@H]1[C@H]([C@H](O)[C@@H]2O)n1cnc2c(C)nc(nc12)C#Cc1ccccc1 Show InChI InChI=1S/C22H21N5O3/c1-12-16-20(26-15(25-12)9-8-13-6-4-3-5-7-13)27(11-24-16)17-14-10-22(14,21(30)23-2)19(29)18(17)28/h3-7,11,14,17-19,28-29H,10H2,1-2H3,(H,23,30)/t14-,17-,18+,19+,22+/m1/s1 | UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 6 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
National Institute of Diabetes and Digestive and Kidney Diseases
Curated by ChEMBL
| Assay Description Displacement of [125I]N6-(4-amino-3-iodobenzyl)adenosine-5'-N-methyl-uronamide from human adenosine A3 receptor expressed in CHO cell membranes incub... |
J Med Chem 59: 3249-63 (2016)
Article DOI: 10.1021/acs.jmedchem.5b01998 BindingDB Entry DOI: 10.7270/Q2WQ05PZ |
More data for this Ligand-Target Pair | |
Transmembrane domain-containing protein TMIGD3
(Homo sapiens (Human)) | BDBM50163884
 (CHEMBL3798200)Show SMILES CNC(=O)[C@@]12C[C@@H]1[C@H]([C@H](O)[C@@H]2O)n1cnc2c(C)nc(nc12)C#Cc1ccc(Cl)s1 Show InChI InChI=1S/C20H18ClN5O3S/c1-9-14-18(25-13(24-9)6-4-10-3-5-12(21)30-10)26(8-23-14)15-11-7-20(11,19(29)22-2)17(28)16(15)27/h3,5,8,11,15-17,27-28H,7H2,1-2H3,(H,22,29)/t11-,15-,16+,17+,20+/m1/s1 | UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 42 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
National Institute of Diabetes and Digestive and Kidney Diseases
Curated by ChEMBL
| Assay Description Displacement of [125I]N6-(4-amino-3-iodobenzyl)adenosine-5'-N-methyl-uronamide from human adenosine A3 receptor expressed in CHO cell membranes incub... |
J Med Chem 59: 3249-63 (2016)
Article DOI: 10.1021/acs.jmedchem.5b01998 BindingDB Entry DOI: 10.7270/Q2WQ05PZ |
More data for this Ligand-Target Pair | |
Transmembrane domain-containing protein TMIGD3
(Homo sapiens (Human)) | BDBM50163883
 (CHEMBL3800509)Show SMILES CNC(=O)[C@@]12C[C@@H]1[C@H]([C@H](O)[C@@H]2O)n1cnc2cnc(nc12)C#Cc1ccc(F)c(F)c1 Show InChI InChI=1S/C21H17F2N5O3/c1-24-20(31)21-7-11(21)16(17(29)18(21)30)28-9-26-14-8-25-15(27-19(14)28)5-3-10-2-4-12(22)13(23)6-10/h2,4,6,8-9,11,16-18,29-30H,7H2,1H3,(H,24,31)/t11-,16-,17+,18+,21+/m1/s1 | UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 124 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
National Institute of Diabetes and Digestive and Kidney Diseases
Curated by ChEMBL
| Assay Description Displacement of [125I]N6-(4-amino-3-iodobenzyl)adenosine-5'-N-methyl-uronamide from human adenosine A3 receptor expressed in CHO cell membranes incub... |
J Med Chem 59: 3249-63 (2016)
Article DOI: 10.1021/acs.jmedchem.5b01998 BindingDB Entry DOI: 10.7270/Q2WQ05PZ |
More data for this Ligand-Target Pair | |
Adenosine receptor A3
(Mus musculus) | BDBM50163874
 (CHEMBL3800048)Show SMILES CNC(=O)[C@@]12C[C@@H]1[C@H]([C@H](O)[C@@H]2O)n1cnc2c(C)nc(nc12)C#Cc1ccccc1 Show InChI InChI=1S/C22H21N5O3/c1-12-16-20(26-15(25-12)9-8-13-6-4-3-5-7-13)27(11-24-16)17-14-10-22(14,21(30)23-2)19(29)18(17)28/h3-7,11,14,17-19,28-29H,10H2,1-2H3,(H,23,30)/t14-,17-,18+,19+,22+/m1/s1 | Reactome pathway
UniProtKB/SwissProt
GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 158 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
National Institute of Diabetes and Digestive and Kidney Diseases
Curated by ChEMBL
| Assay Description Displacement of [125I]N6-(4-amino-3-iodobenzyl)adenosine-5'-Nmethyluronamide from mouse adenosine A3 receptor expressed in HEK293 cell membranes incu... |
J Med Chem 59: 3249-63 (2016)
Article DOI: 10.1021/acs.jmedchem.5b01998 BindingDB Entry DOI: 10.7270/Q2WQ05PZ |
More data for this Ligand-Target Pair | |
Transmembrane domain-containing protein TMIGD3
(Homo sapiens (Human)) | BDBM50163881
 (CHEMBL3798963)Show SMILES CNC(=O)[C@@]12C[C@@H]1[C@H]([C@H](O)[C@@H]2O)n1cnc2c(C)nc(nc12)C#Cc1cnccn1 Show InChI InChI=1S/C20H19N7O3/c1-10-14-18(26-13(25-10)4-3-11-8-22-5-6-23-11)27(9-24-14)15-12-7-20(12,19(30)21-2)17(29)16(15)28/h5-6,8-9,12,15-17,28-29H,7H2,1-2H3,(H,21,30)/t12-,15-,16+,17+,20+/m1/s1 | UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 343 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
National Institute of Diabetes and Digestive and Kidney Diseases
Curated by ChEMBL
| Assay Description Displacement of [125I]N6-(4-amino-3-iodobenzyl)adenosine-5'-N-methyl-uronamide from human adenosine A3 receptor expressed in CHO cell membranes incub... |
J Med Chem 59: 3249-63 (2016)
Article DOI: 10.1021/acs.jmedchem.5b01998 BindingDB Entry DOI: 10.7270/Q2WQ05PZ |
More data for this Ligand-Target Pair | |
Transmembrane domain-containing protein TMIGD3
(Homo sapiens (Human)) | BDBM50163880
 (CHEMBL3800202)Show SMILES CNC(=O)[C@@]12C[C@@H]1[C@H]([C@H](O)[C@@H]2O)n1cnc2cnc(NC)nc12 Show InChI InChI=1S/C14H18N6O3/c1-15-12(23)14-3-6(14)8(9(21)10(14)22)20-5-18-7-4-17-13(16-2)19-11(7)20/h4-6,8-10,21-22H,3H2,1-2H3,(H,15,23)(H,16,17,19)/t6-,8-,9+,10+,14+/m1/s1 | UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 604 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
National Institute of Diabetes and Digestive and Kidney Diseases
Curated by ChEMBL
| Assay Description Displacement of [125I]N6-(4-amino-3-iodobenzyl)adenosine-5'-N-methyl-uronamide from human adenosine A3 receptor expressed in CHO cell membranes incub... |
J Med Chem 59: 3249-63 (2016)
Article DOI: 10.1021/acs.jmedchem.5b01998 BindingDB Entry DOI: 10.7270/Q2WQ05PZ |
More data for this Ligand-Target Pair | |
Transmembrane domain-containing protein TMIGD3
(Homo sapiens (Human)) | BDBM50163877
 (CHEMBL3799847)Show SMILES CNC(=O)[C@@]12C[C@@H]1[C@H]([C@H](O)[C@@H]2O)n1cnc2c(OC)nc(nc12)C#Cc1ccc(Cl)s1 Show InChI InChI=1S/C20H18ClN5O4S/c1-22-19(29)20-7-10(20)14(15(27)16(20)28)26-8-23-13-17(26)24-12(25-18(13)30-2)6-4-9-3-5-11(21)31-9/h3,5,8,10,14-16,27-28H,7H2,1-2H3,(H,22,29)/t10-,14-,15+,16+,20+/m1/s1 | UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 684 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
National Institute of Diabetes and Digestive and Kidney Diseases
Curated by ChEMBL
| Assay Description Displacement of [125I]N6-(4-amino-3-iodobenzyl)adenosine-5'-N-methyl-uronamide from human adenosine A3 receptor expressed in CHO cell membranes incub... |
J Med Chem 59: 3249-63 (2016)
Article DOI: 10.1021/acs.jmedchem.5b01998 BindingDB Entry DOI: 10.7270/Q2WQ05PZ |
More data for this Ligand-Target Pair | |
Adenosine receptor A3
(Mus musculus) | BDBM50163884
 (CHEMBL3798200)Show SMILES CNC(=O)[C@@]12C[C@@H]1[C@H]([C@H](O)[C@@H]2O)n1cnc2c(C)nc(nc12)C#Cc1ccc(Cl)s1 Show InChI InChI=1S/C20H18ClN5O3S/c1-9-14-18(25-13(24-9)6-4-10-3-5-12(21)30-10)26(8-23-14)15-11-7-20(11,19(29)22-2)17(28)16(15)27/h3,5,8,11,15-17,27-28H,7H2,1-2H3,(H,22,29)/t11-,15-,16+,17+,20+/m1/s1 | Reactome pathway
UniProtKB/SwissProt
GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 722 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
National Institute of Diabetes and Digestive and Kidney Diseases
Curated by ChEMBL
| Assay Description Agonist activity at mouse adenosine A3 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP accumulation p... |
J Med Chem 59: 3249-63 (2016)
Article DOI: 10.1021/acs.jmedchem.5b01998 BindingDB Entry DOI: 10.7270/Q2WQ05PZ |
More data for this Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50163877
 (CHEMBL3799847)Show SMILES CNC(=O)[C@@]12C[C@@H]1[C@H]([C@H](O)[C@@H]2O)n1cnc2c(OC)nc(nc12)C#Cc1ccc(Cl)s1 Show InChI InChI=1S/C20H18ClN5O4S/c1-22-19(29)20-7-10(20)14(15(27)16(20)28)26-8-23-13-17(26)24-12(25-18(13)30-2)6-4-9-3-5-11(21)31-9/h3,5,8,10,14-16,27-28H,7H2,1-2H3,(H,22,29)/t10-,14-,15+,16+,20+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 796 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
National Institute of Diabetes and Digestive and Kidney Diseases
Curated by ChEMBL
| Assay Description Displacement of [3H]N6-R-phenylisopropyladenosine from human adenosine A1 receptor expressed in CHO cell membranes incubated for 60 mins by liquid sc... |
J Med Chem 59: 3249-63 (2016)
Article DOI: 10.1021/acs.jmedchem.5b01998 BindingDB Entry DOI: 10.7270/Q2WQ05PZ |
More data for this Ligand-Target Pair | |
Transmembrane domain-containing protein TMIGD3
(Homo sapiens (Human)) | BDBM50163879
 (CHEMBL3798076)Show SMILES CNC(=O)[C@@]12C[C@@H]1[C@H]([C@H](O)[C@@H]2O)n1cnc2cnc(\C=C(/O)c3cnccn3)nc12 Show InChI InChI=1S/C19H19N7O4/c1-20-18(30)19-5-9(19)14(15(28)16(19)29)26-8-24-11-7-23-13(25-17(11)26)4-12(27)10-6-21-2-3-22-10/h2-4,6-9,14-16,27-29H,5H2,1H3,(H,20,30)/b12-4-/t9-,14-,15+,16+,19+/m1/s1 | UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 1.48E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
National Institute of Diabetes and Digestive and Kidney Diseases
Curated by ChEMBL
| Assay Description Displacement of [125I]N6-(4-amino-3-iodobenzyl)adenosine-5'-N-methyl-uronamide from human adenosine A3 receptor expressed in CHO cell membranes incub... |
J Med Chem 59: 3249-63 (2016)
Article DOI: 10.1021/acs.jmedchem.5b01998 BindingDB Entry DOI: 10.7270/Q2WQ05PZ |
More data for this Ligand-Target Pair | |
Delta-type opioid receptor
(Homo sapiens (Human)) | BDBM50163884
 (CHEMBL3798200)Show SMILES CNC(=O)[C@@]12C[C@@H]1[C@H]([C@H](O)[C@@H]2O)n1cnc2c(C)nc(nc12)C#Cc1ccc(Cl)s1 Show InChI InChI=1S/C20H18ClN5O3S/c1-9-14-18(25-13(24-9)6-4-10-3-5-12(21)30-10)26(8-23-14)15-11-7-20(11,19(29)22-2)17(28)16(15)27/h3,5,8,11,15-17,27-28H,7H2,1-2H3,(H,22,29)/t11-,15-,16+,17+,20+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 5.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
National Institute of Diabetes and Digestive and Kidney Diseases
Curated by ChEMBL
| Assay Description Inhibition of delta opioid receptor (unknown origin) by PDSP assay |
J Med Chem 59: 3249-63 (2016)
Article DOI: 10.1021/acs.jmedchem.5b01998 BindingDB Entry DOI: 10.7270/Q2WQ05PZ |
More data for this Ligand-Target Pair | |
Sodium channel protein type 5 subunit alpha
(Homo sapiens (Human)) | BDBM50163886
 (CHEMBL3800588)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC3=O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc2cccc3ccccc23)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]2CCCN2C1=O)C(C)C Show InChI InChI=1S/C185H276N52O44S7/c1-13-99(10)148-182(281)237-70-37-56-140(237)177(276)223-131(83-145(247)248)166(265)220-126(77-105-44-32-43-104-42-20-21-45-109(104)105)161(260)221-130(82-144(245)246)165(264)210-116(51-27-31-65-189)157(256)227-136-91-286-284-89-134(170(269)212-114(49-25-29-63-187)154(253)218-125(76-103-57-59-108(240)60-58-103)168(267)233-146(97(6)7)178(277)215-121(150(192)249)74-101-38-16-14-17-39-101)229-162(261)127(78-106-84-203-112-47-23-22-46-110(106)112)219-155(254)113(48-24-28-62-186)209-163(262)128(79-107-85-199-94-205-107)224-180(279)149(100(11)239)235-159(258)118(53-34-67-201-184(195)196)211-169(268)132(87-238)225-173(272)137-92-287-288-93-138(175(274)234-148)228-156(255)115(50-26-30-64-188)207-153(252)117(52-33-66-200-183(193)194)208-158(257)119(61-71-282-12)213-160(259)124(75-102-40-18-15-19-41-102)206-142(242)86-204-152(251)122(72-95(2)3)216-172(271)133(226-151(250)111(190)80-143(243)244)88-283-285-90-135(230-174(136)273)171(270)214-120(54-35-68-202-185(197)198)181(280)236-69-36-55-139(236)176(275)222-129(81-141(191)241)164(263)217-123(73-96(4)5)167(266)232-147(98(8)9)179(278)231-137/h14-23,32,38-47,57-60,84-85,94-100,111,113-140,146-149,203,238-240H,13,24-31,33-37,48-56,61-83,86-93,186-190H2,1-12H3,(H2,191,241)(H2,192,249)(H,199,205)(H,204,251)(H,206,242)(H,207,252)(H,208,257)(H,209,262)(H,210,264)(H,211,268)(H,212,269)(H,213,259)(H,214,270)(H,215,277)(H,216,271)(H,217,263)(H,218,253)(H,219,254)(H,220,265)(H,221,260)(H,222,275)(H,223,276)(H,224,279)(H,225,272)(H,226,250)(H,227,256)(H,228,255)(H,229,261)(H,230,273)(H,231,278)(H,232,266)(H,233,267)(H,234,274)(H,235,258)(H,243,244)(H,245,246)(H,247,248)(H4,193,194,200)(H4,195,196,201)(H4,197,198,202)/t99-,100+,111-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,146-,147-,148-,149-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 7.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc
Curated by ChEMBL
| Assay Description Inhibition of human Nav1.5 expressed in HEK293 cells by whole cell patch clamp electrophysiology method |
J Med Chem 59: 2704-17 (2016)
Article DOI: 10.1021/acs.jmedchem.5b01947 BindingDB Entry DOI: 10.7270/Q2S184D5 |
More data for this Ligand-Target Pair | |
Sodium channel protein type 5 subunit alpha
(Homo sapiens (Human)) | BDBM50163886
 (CHEMBL3800588)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC3=O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc2cccc3ccccc23)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]2CCCN2C1=O)C(C)C Show InChI InChI=1S/C185H276N52O44S7/c1-13-99(10)148-182(281)237-70-37-56-140(237)177(276)223-131(83-145(247)248)166(265)220-126(77-105-44-32-43-104-42-20-21-45-109(104)105)161(260)221-130(82-144(245)246)165(264)210-116(51-27-31-65-189)157(256)227-136-91-286-284-89-134(170(269)212-114(49-25-29-63-187)154(253)218-125(76-103-57-59-108(240)60-58-103)168(267)233-146(97(6)7)178(277)215-121(150(192)249)74-101-38-16-14-17-39-101)229-162(261)127(78-106-84-203-112-47-23-22-46-110(106)112)219-155(254)113(48-24-28-62-186)209-163(262)128(79-107-85-199-94-205-107)224-180(279)149(100(11)239)235-159(258)118(53-34-67-201-184(195)196)211-169(268)132(87-238)225-173(272)137-92-287-288-93-138(175(274)234-148)228-156(255)115(50-26-30-64-188)207-153(252)117(52-33-66-200-183(193)194)208-158(257)119(61-71-282-12)213-160(259)124(75-102-40-18-15-19-41-102)206-142(242)86-204-152(251)122(72-95(2)3)216-172(271)133(226-151(250)111(190)80-143(243)244)88-283-285-90-135(230-174(136)273)171(270)214-120(54-35-68-202-185(197)198)181(280)236-69-36-55-139(236)176(275)222-129(81-141(191)241)164(263)217-123(73-96(4)5)167(266)232-147(98(8)9)179(278)231-137/h14-23,32,38-47,57-60,84-85,94-100,111,113-140,146-149,203,238-240H,13,24-31,33-37,48-56,61-83,86-93,186-190H2,1-12H3,(H2,191,241)(H2,192,249)(H,199,205)(H,204,251)(H,206,242)(H,207,252)(H,208,257)(H,209,262)(H,210,264)(H,211,268)(H,212,269)(H,213,259)(H,214,270)(H,215,277)(H,216,271)(H,217,263)(H,218,253)(H,219,254)(H,220,265)(H,221,260)(H,222,275)(H,223,276)(H,224,279)(H,225,272)(H,226,250)(H,227,256)(H,228,255)(H,229,261)(H,230,273)(H,231,278)(H,232,266)(H,233,267)(H,234,274)(H,235,258)(H,243,244)(H,245,246)(H,247,248)(H4,193,194,200)(H4,195,196,201)(H4,197,198,202)/t99-,100+,111-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,146-,147-,148-,149-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc
Curated by ChEMBL
| Assay Description Inhibition of human Nav1.5 expressed in HEK293 cells assessed as inward peak current by ion-works quattro patch clamp electrophysiology method |
J Med Chem 59: 2704-17 (2016)
Article DOI: 10.1021/acs.jmedchem.5b01947 BindingDB Entry DOI: 10.7270/Q2S184D5 |
More data for this Ligand-Target Pair | |
Sodium channel protein type 9 subunit alpha
(Homo sapiens (Human)) | BDBM50163886
 (CHEMBL3800588)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC3=O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc2cccc3ccccc23)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]2CCCN2C1=O)C(C)C Show InChI InChI=1S/C185H276N52O44S7/c1-13-99(10)148-182(281)237-70-37-56-140(237)177(276)223-131(83-145(247)248)166(265)220-126(77-105-44-32-43-104-42-20-21-45-109(104)105)161(260)221-130(82-144(245)246)165(264)210-116(51-27-31-65-189)157(256)227-136-91-286-284-89-134(170(269)212-114(49-25-29-63-187)154(253)218-125(76-103-57-59-108(240)60-58-103)168(267)233-146(97(6)7)178(277)215-121(150(192)249)74-101-38-16-14-17-39-101)229-162(261)127(78-106-84-203-112-47-23-22-46-110(106)112)219-155(254)113(48-24-28-62-186)209-163(262)128(79-107-85-199-94-205-107)224-180(279)149(100(11)239)235-159(258)118(53-34-67-201-184(195)196)211-169(268)132(87-238)225-173(272)137-92-287-288-93-138(175(274)234-148)228-156(255)115(50-26-30-64-188)207-153(252)117(52-33-66-200-183(193)194)208-158(257)119(61-71-282-12)213-160(259)124(75-102-40-18-15-19-41-102)206-142(242)86-204-152(251)122(72-95(2)3)216-172(271)133(226-151(250)111(190)80-143(243)244)88-283-285-90-135(230-174(136)273)171(270)214-120(54-35-68-202-185(197)198)181(280)236-69-36-55-139(236)176(275)222-129(81-141(191)241)164(263)217-123(73-96(4)5)167(266)232-147(98(8)9)179(278)231-137/h14-23,32,38-47,57-60,84-85,94-100,111,113-140,146-149,203,238-240H,13,24-31,33-37,48-56,61-83,86-93,186-190H2,1-12H3,(H2,191,241)(H2,192,249)(H,199,205)(H,204,251)(H,206,242)(H,207,252)(H,208,257)(H,209,262)(H,210,264)(H,211,268)(H,212,269)(H,213,259)(H,214,270)(H,215,277)(H,216,271)(H,217,263)(H,218,253)(H,219,254)(H,220,265)(H,221,260)(H,222,275)(H,223,276)(H,224,279)(H,225,272)(H,226,250)(H,227,256)(H,228,255)(H,229,261)(H,230,273)(H,231,278)(H,232,266)(H,233,267)(H,234,274)(H,235,258)(H,243,244)(H,245,246)(H,247,248)(H4,193,194,200)(H4,195,196,201)(H4,197,198,202)/t99-,100+,111-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,146-,147-,148-,149-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc
Curated by ChEMBL
| Assay Description Inhibition of human Nav1.7 expressed in HEK293 cells assessed as inward peak current by ion-works quattro patch clamp electrophysiology method |
J Med Chem 59: 2704-17 (2016)
Article DOI: 10.1021/acs.jmedchem.5b01947 BindingDB Entry DOI: 10.7270/Q2S184D5 |
More data for this Ligand-Target Pair | |
Voltage-gated sodium channel subunit alpha Nav1.4 (Nav1.4)
(Homo sapiens (Human)) | BDBM50163886
 (CHEMBL3800588)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC3=O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc2cccc3ccccc23)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]2CCCN2C1=O)C(C)C Show InChI InChI=1S/C185H276N52O44S7/c1-13-99(10)148-182(281)237-70-37-56-140(237)177(276)223-131(83-145(247)248)166(265)220-126(77-105-44-32-43-104-42-20-21-45-109(104)105)161(260)221-130(82-144(245)246)165(264)210-116(51-27-31-65-189)157(256)227-136-91-286-284-89-134(170(269)212-114(49-25-29-63-187)154(253)218-125(76-103-57-59-108(240)60-58-103)168(267)233-146(97(6)7)178(277)215-121(150(192)249)74-101-38-16-14-17-39-101)229-162(261)127(78-106-84-203-112-47-23-22-46-110(106)112)219-155(254)113(48-24-28-62-186)209-163(262)128(79-107-85-199-94-205-107)224-180(279)149(100(11)239)235-159(258)118(53-34-67-201-184(195)196)211-169(268)132(87-238)225-173(272)137-92-287-288-93-138(175(274)234-148)228-156(255)115(50-26-30-64-188)207-153(252)117(52-33-66-200-183(193)194)208-158(257)119(61-71-282-12)213-160(259)124(75-102-40-18-15-19-41-102)206-142(242)86-204-152(251)122(72-95(2)3)216-172(271)133(226-151(250)111(190)80-143(243)244)88-283-285-90-135(230-174(136)273)171(270)214-120(54-35-68-202-185(197)198)181(280)236-69-36-55-139(236)176(275)222-129(81-141(191)241)164(263)217-123(73-96(4)5)167(266)232-147(98(8)9)179(278)231-137/h14-23,32,38-47,57-60,84-85,94-100,111,113-140,146-149,203,238-240H,13,24-31,33-37,48-56,61-83,86-93,186-190H2,1-12H3,(H2,191,241)(H2,192,249)(H,199,205)(H,204,251)(H,206,242)(H,207,252)(H,208,257)(H,209,262)(H,210,264)(H,211,268)(H,212,269)(H,213,259)(H,214,270)(H,215,277)(H,216,271)(H,217,263)(H,218,253)(H,219,254)(H,220,265)(H,221,260)(H,222,275)(H,223,276)(H,224,279)(H,225,272)(H,226,250)(H,227,256)(H,228,255)(H,229,261)(H,230,273)(H,231,278)(H,232,266)(H,233,267)(H,234,274)(H,235,258)(H,243,244)(H,245,246)(H,247,248)(H4,193,194,200)(H4,195,196,201)(H4,197,198,202)/t99-,100+,111-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,146-,147-,148-,149-/m0/s1 | PDB
Reactome pathway
UniProtKB/SwissProt
antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 280 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc
Curated by ChEMBL
| Assay Description Inhibition of human Nav1.4 expressed in HEK293 cells by whole cell patch clamp electrophysiology method |
J Med Chem 59: 2704-17 (2016)
Article DOI: 10.1021/acs.jmedchem.5b01947 BindingDB Entry DOI: 10.7270/Q2S184D5 |
More data for this Ligand-Target Pair | |
Voltage-gated sodium channel subunit alpha Nav1.4 (Nav1.4)
(Homo sapiens (Human)) | BDBM50163886
 (CHEMBL3800588)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC3=O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc2cccc3ccccc23)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]2CCCN2C1=O)C(C)C Show InChI InChI=1S/C185H276N52O44S7/c1-13-99(10)148-182(281)237-70-37-56-140(237)177(276)223-131(83-145(247)248)166(265)220-126(77-105-44-32-43-104-42-20-21-45-109(104)105)161(260)221-130(82-144(245)246)165(264)210-116(51-27-31-65-189)157(256)227-136-91-286-284-89-134(170(269)212-114(49-25-29-63-187)154(253)218-125(76-103-57-59-108(240)60-58-103)168(267)233-146(97(6)7)178(277)215-121(150(192)249)74-101-38-16-14-17-39-101)229-162(261)127(78-106-84-203-112-47-23-22-46-110(106)112)219-155(254)113(48-24-28-62-186)209-163(262)128(79-107-85-199-94-205-107)224-180(279)149(100(11)239)235-159(258)118(53-34-67-201-184(195)196)211-169(268)132(87-238)225-173(272)137-92-287-288-93-138(175(274)234-148)228-156(255)115(50-26-30-64-188)207-153(252)117(52-33-66-200-183(193)194)208-158(257)119(61-71-282-12)213-160(259)124(75-102-40-18-15-19-41-102)206-142(242)86-204-152(251)122(72-95(2)3)216-172(271)133(226-151(250)111(190)80-143(243)244)88-283-285-90-135(230-174(136)273)171(270)214-120(54-35-68-202-185(197)198)181(280)236-69-36-55-139(236)176(275)222-129(81-141(191)241)164(263)217-123(73-96(4)5)167(266)232-147(98(8)9)179(278)231-137/h14-23,32,38-47,57-60,84-85,94-100,111,113-140,146-149,203,238-240H,13,24-31,33-37,48-56,61-83,86-93,186-190H2,1-12H3,(H2,191,241)(H2,192,249)(H,199,205)(H,204,251)(H,206,242)(H,207,252)(H,208,257)(H,209,262)(H,210,264)(H,211,268)(H,212,269)(H,213,259)(H,214,270)(H,215,277)(H,216,271)(H,217,263)(H,218,253)(H,219,254)(H,220,265)(H,221,260)(H,222,275)(H,223,276)(H,224,279)(H,225,272)(H,226,250)(H,227,256)(H,228,255)(H,229,261)(H,230,273)(H,231,278)(H,232,266)(H,233,267)(H,234,274)(H,235,258)(H,243,244)(H,245,246)(H,247,248)(H4,193,194,200)(H4,195,196,201)(H4,197,198,202)/t99-,100+,111-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,146-,147-,148-,149-/m0/s1 | PDB
Reactome pathway
UniProtKB/SwissProt
antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc
Curated by ChEMBL
| Assay Description Inhibition of human Nav1.4 expressed in HEK293 cells assessed as inward peak current by ion-works quattro patch clamp electrophysiology method |
J Med Chem 59: 2704-17 (2016)
Article DOI: 10.1021/acs.jmedchem.5b01947 BindingDB Entry DOI: 10.7270/Q2S184D5 |
More data for this Ligand-Target Pair | |
Transmembrane domain-containing protein TMIGD3
(Homo sapiens (Human)) | BDBM50163874
 (CHEMBL3800048)Show SMILES CNC(=O)[C@@]12C[C@@H]1[C@H]([C@H](O)[C@@H]2O)n1cnc2c(C)nc(nc12)C#Cc1ccccc1 Show InChI InChI=1S/C22H21N5O3/c1-12-16-20(26-15(25-12)9-8-13-6-4-3-5-7-13)27(11-24-16)17-14-10-22(14,21(30)23-2)19(29)18(17)28/h3-7,11,14,17-19,28-29H,10H2,1-2H3,(H,23,30)/t14-,17-,18+,19+,22+/m1/s1 | UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 3.20 | n/a | n/a | n/a | n/a |
National Institute of Diabetes and Digestive and Kidney Diseases
Curated by ChEMBL
| Assay Description Agonist activity at recombinant human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation p... |
J Med Chem 59: 3249-63 (2016)
Article DOI: 10.1021/acs.jmedchem.5b01998 BindingDB Entry DOI: 10.7270/Q2WQ05PZ |
More data for this Ligand-Target Pair | |
Transmembrane domain-containing protein TMIGD3
(Homo sapiens (Human)) | BDBM50163884
 (CHEMBL3798200)Show SMILES CNC(=O)[C@@]12C[C@@H]1[C@H]([C@H](O)[C@@H]2O)n1cnc2c(C)nc(nc12)C#Cc1ccc(Cl)s1 Show InChI InChI=1S/C20H18ClN5O3S/c1-9-14-18(25-13(24-9)6-4-10-3-5-12(21)30-10)26(8-23-14)15-11-7-20(11,19(29)22-2)17(28)16(15)27/h3,5,8,11,15-17,27-28H,7H2,1-2H3,(H,22,29)/t11-,15-,16+,17+,20+/m1/s1 | UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 13 | n/a | n/a | n/a | n/a |
National Institute of Diabetes and Digestive and Kidney Diseases
Curated by ChEMBL
| Assay Description Agonist activity at recombinant human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation p... |
J Med Chem 59: 3249-63 (2016)
Article DOI: 10.1021/acs.jmedchem.5b01998 BindingDB Entry DOI: 10.7270/Q2WQ05PZ |
More data for this Ligand-Target Pair | |
Adenosine receptor A3
(Mus musculus) | BDBM50163874
 (CHEMBL3800048)Show SMILES CNC(=O)[C@@]12C[C@@H]1[C@H]([C@H](O)[C@@H]2O)n1cnc2c(C)nc(nc12)C#Cc1ccccc1 Show InChI InChI=1S/C22H21N5O3/c1-12-16-20(26-15(25-12)9-8-13-6-4-3-5-7-13)27(11-24-16)17-14-10-22(14,21(30)23-2)19(29)18(17)28/h3-7,11,14,17-19,28-29H,10H2,1-2H3,(H,23,30)/t14-,17-,18+,19+,22+/m1/s1 | Reactome pathway
UniProtKB/SwissProt
GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 20 | n/a | n/a | n/a | n/a |
National Institute of Diabetes and Digestive and Kidney Diseases
Curated by ChEMBL
| Assay Description Agonist activity at mouse adenosine A3 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP accumulation p... |
J Med Chem 59: 3249-63 (2016)
Article DOI: 10.1021/acs.jmedchem.5b01998 BindingDB Entry DOI: 10.7270/Q2WQ05PZ |
More data for this Ligand-Target Pair | |
cGMP-specific 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50257322
 (CHEMBL522338 | ethyl 4-methyl-2-(4-(methylamino)-6...)Show SMILES CCOC(=O)c1sc(Nc2nc(NC)cc(NCc3ccc(cc3)S(N)(=O)=O)n2)nc1C Show InChI InChI=1S/C19H23N7O4S2/c1-4-30-17(27)16-11(2)23-19(31-16)26-18-24-14(21-3)9-15(25-18)22-10-12-5-7-13(8-6-12)32(20,28)29/h5-9H,4,10H2,1-3H3,(H2,20,28,29)(H3,21,22,23,24,25,26) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 65 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Pharmaceutical Research Institute
Curated by ChEMBL
| Assay Description Inhibition of PDE5 |
Bioorg Med Chem Lett 19: 1935-8 (2009)
Article DOI: 10.1016/j.bmcl.2009.02.060 BindingDB Entry DOI: 10.7270/Q2TM7B02 |
More data for this Ligand-Target Pair | |
Sodium channel protein type 9 subunit alpha
(Homo sapiens (Human)) | BDBM50163886
 (CHEMBL3800588)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC3=O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc2cccc3ccccc23)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]2CCCN2C1=O)C(C)C Show InChI InChI=1S/C185H276N52O44S7/c1-13-99(10)148-182(281)237-70-37-56-140(237)177(276)223-131(83-145(247)248)166(265)220-126(77-105-44-32-43-104-42-20-21-45-109(104)105)161(260)221-130(82-144(245)246)165(264)210-116(51-27-31-65-189)157(256)227-136-91-286-284-89-134(170(269)212-114(49-25-29-63-187)154(253)218-125(76-103-57-59-108(240)60-58-103)168(267)233-146(97(6)7)178(277)215-121(150(192)249)74-101-38-16-14-17-39-101)229-162(261)127(78-106-84-203-112-47-23-22-46-110(106)112)219-155(254)113(48-24-28-62-186)209-163(262)128(79-107-85-199-94-205-107)224-180(279)149(100(11)239)235-159(258)118(53-34-67-201-184(195)196)211-169(268)132(87-238)225-173(272)137-92-287-288-93-138(175(274)234-148)228-156(255)115(50-26-30-64-188)207-153(252)117(52-33-66-200-183(193)194)208-158(257)119(61-71-282-12)213-160(259)124(75-102-40-18-15-19-41-102)206-142(242)86-204-152(251)122(72-95(2)3)216-172(271)133(226-151(250)111(190)80-143(243)244)88-283-285-90-135(230-174(136)273)171(270)214-120(54-35-68-202-185(197)198)181(280)236-69-36-55-139(236)176(275)222-129(81-141(191)241)164(263)217-123(73-96(4)5)167(266)232-147(98(8)9)179(278)231-137/h14-23,32,38-47,57-60,84-85,94-100,111,113-140,146-149,203,238-240H,13,24-31,33-37,48-56,61-83,86-93,186-190H2,1-12H3,(H2,191,241)(H2,192,249)(H,199,205)(H,204,251)(H,206,242)(H,207,252)(H,208,257)(H,209,262)(H,210,264)(H,211,268)(H,212,269)(H,213,259)(H,214,270)(H,215,277)(H,216,271)(H,217,263)(H,218,253)(H,219,254)(H,220,265)(H,221,260)(H,222,275)(H,223,276)(H,224,279)(H,225,272)(H,226,250)(H,227,256)(H,228,255)(H,229,261)(H,230,273)(H,231,278)(H,232,266)(H,233,267)(H,234,274)(H,235,258)(H,243,244)(H,245,246)(H,247,248)(H4,193,194,200)(H4,195,196,201)(H4,197,198,202)/t99-,100+,111-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,146-,147-,148-,149-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc
Curated by ChEMBL
| Assay Description Inhibition of human Nav1.7 expressed in HEK293 cells by whole cell patch clamp electrophysiology method |
J Med Chem 59: 2704-17 (2016)
Article DOI: 10.1021/acs.jmedchem.5b01947 BindingDB Entry DOI: 10.7270/Q2S184D5 |
More data for this Ligand-Target Pair | |
cGMP-specific 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50257381
 (CHEMBL493109 | ethyl 2-(4-(3,4-dimethoxybenzylamin...)Show SMILES CCOC(=O)c1sc(Nc2nc(NCc3ccc(OC)c(OC)c3)cc(n2)N2CCNCC2)nc1C Show InChI InChI=1S/C24H31N7O4S/c1-5-35-22(32)21-15(2)27-24(36-21)30-23-28-19(13-20(29-23)31-10-8-25-9-11-31)26-14-16-6-7-17(33-3)18(12-16)34-4/h6-7,12-13,25H,5,8-11,14H2,1-4H3,(H2,26,27,28,29,30) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 320 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Pharmaceutical Research Institute
Curated by ChEMBL
| Assay Description Inhibition of PDE5 |
Bioorg Med Chem Lett 19: 1935-8 (2009)
Article DOI: 10.1016/j.bmcl.2009.02.060 BindingDB Entry DOI: 10.7270/Q2TM7B02 |
More data for this Ligand-Target Pair | |
cGMP-specific 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50257323
 (CHEMBL493552 | ethyl 4-methyl-2-(4-(piperazin-1-yl...)Show SMILES CCOC(=O)c1sc(Nc2nc(NCc3ccc(cc3)S(N)(=O)=O)cc(n2)N2CCNCC2)nc1C Show InChI InChI=1S/C22H28N8O4S2/c1-3-34-20(31)19-14(2)26-22(35-19)29-21-27-17(12-18(28-21)30-10-8-24-9-11-30)25-13-15-4-6-16(7-5-15)36(23,32)33/h4-7,12,24H,3,8-11,13H2,1-2H3,(H2,23,32,33)(H2,25,26,27,28,29) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 72 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Pharmaceutical Research Institute
Curated by ChEMBL
| Assay Description Inhibition of PDE5 |
Bioorg Med Chem Lett 19: 1935-8 (2009)
Article DOI: 10.1016/j.bmcl.2009.02.060 BindingDB Entry DOI: 10.7270/Q2TM7B02 |
More data for this Ligand-Target Pair | |